Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Low-Grade”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Testing effectiveness (Phase 2)Study completedNCT01663714
What this trial is testing

Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.

Who this might be right for
Lymphoma, Non-Hodgkin
GlaxoSmithKline 30
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Testing effectiveness (Phase 2)Study completedNCT00546377
What this trial is testing

Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)UnknownNCT00036426
What this trial is testing

Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Low-Grade
Favrille 22
Testing effectiveness (Phase 2)Study completedNCT00044902
What this trial is testing

Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Early research (Phase 1)Ended earlyNCT00880867
What this trial is testing

Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma

Who this might be right for
B Cell LymphomaT Cell Lymphoma
Nevada Cancer Institute 3
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00536458
What this trial is testing

Treatment of Localized Low Grade Lymphomas

Who this might be right for
Lymphoma, Low-Grade
French Innovative Leukemia Organisation 132
Testing effectiveness (Phase 2)WithdrawnNCT01263418
What this trial is testing

Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, B-Cell, Marginal Zone+2 more
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT01695941
What this trial is testing

Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00051025
What this trial is testing

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin's LymphomaLymphoma, B-cellLymphoma, Low-grade
Eisai Inc. 9
Early research (Phase 1)Study completedNCT00338494
What this trial is testing

Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma

Who this might be right for
B-Cell Lymphoma
Yale University 16
Not applicableStudy completedNCT00387023
What this trial is testing

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaLymphoma
M.D. Anderson Cancer Center 12
Not applicableStudy completedNCT00005799
What this trial is testing

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more
Fred Hutchinson Cancer Center 55
Testing effectiveness (Phase 2)Study completedNCT00003402
What this trial is testing

Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
University of Maryland, Baltimore 35
Testing effectiveness (Phase 2)Study completedNCT01181271
What this trial is testing

Tandem Auto-Allo Transplant for Lymphoma

Who this might be right for
Diffuse, Large B-Cell, LymphomaLymphoma, Low-GradeT-Cell Lymphoma+4 more
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)UnknownNCT00041730
What this trial is testing

Rituxan Plus FavId (Idiotype Vaccine) for Low-grade Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Favrille 90
Early research (Phase 1)Looking for participantsNCT06708897
What this trial is testing

ZE50-0134 in Relapsed and Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Select Low-grad Lymphomas

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)
Lomond Therapeutics Holdings, Inc. 66
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Testing effectiveness (Phase 2)Study completedNCT00003615
What this trial is testing

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 77
Load More Results